Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05240131
Title A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).
Recruitment Recruiting
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Galecto Biotech AB
Age Groups: adult | senior
Covered Countries ITA | FRA | ESP

Additional content available in CKB BOOST